77 related articles for article (PubMed ID: 2187953)
1. Dissociation of thymidine incorporation and transferrin receptor expression from cell growth and c-myc accumulation in alpha-interferon-treated cells.
Meadows LM; George DJ; Kaufman RE
J Biol Response Mod; 1990 Apr; 9(2):212-20. PubMed ID: 2187953
[TBL] [Abstract][Full Text] [Related]
2. Effect of curcumin on cell cycle progression and apoptosis in vascular smooth muscle cells.
Chen HW; Huang HC
Br J Pharmacol; 1998 Jul; 124(6):1029-40. PubMed ID: 9720770
[TBL] [Abstract][Full Text] [Related]
3. Effects of interferon-beta on Daudi cells and on small cell lung carcinoma cells which over-express the c-myc oncogene.
Pape KA; Floyd-Smith G
Anticancer Res; 1989; 9(6):1737-42. PubMed ID: 2560625
[TBL] [Abstract][Full Text] [Related]
4. Regulation of c-fgr proto-oncogene expression in Burkitt's lymphoma cells: effect of interferon treatment and relationship to EBV status and c-myc mRNA levels.
Sharp NA; Luscombe MJ; Clemens MJ
Oncogene; 1989 Aug; 4(8):1043-6. PubMed ID: 2548145
[TBL] [Abstract][Full Text] [Related]
5. Modulation of c-myc oncogene expression by phorbol ester and interferon-gamma: appraisal by flow cytometry.
Mohamed AN; Nakeff A; Mohammad RM; KuKuruga M; al-Katib A
Oncogene; 1988 Oct; 3(4):429-35. PubMed ID: 3152600
[TBL] [Abstract][Full Text] [Related]
6. Proliferation of the human colon carcinoma cell line HT29: autocrine growth and deregulated expression of the c-myc oncogene.
Forgue-Lafitte ME; Coudray AM; Bréant B; Mester J
Cancer Res; 1989 Dec; 49(23):6566-71. PubMed ID: 2684395
[TBL] [Abstract][Full Text] [Related]
7. Modulation of nuclear proto-oncogene expression and cellular growth in myeloid leukemic cells by human interferon alpha.
Marshall AH; Alper D; Hiscott J
J Cell Physiol; 1988 May; 135(2):324-31. PubMed ID: 3163696
[TBL] [Abstract][Full Text] [Related]
8. Efficient induction of focus formation in a subclone of NIH3T3 cells by c-myc and its inhibition by serum and by growth factors.
Blondel B; Talbot N; Merlo GR; Wychowski C; Yokozaki H; Valverius EM; Salomon DS; Bassin RH
Oncogene; 1990 Jun; 5(6):857-65. PubMed ID: 2193293
[TBL] [Abstract][Full Text] [Related]
9. Relationship of cellular oncogene expression to inhibition of growth and induction of differentiation of Daudi cells by interferons or TPA.
Clemens MJ; Tilleray VJ; James R; Gewert DR
J Cell Biochem; 1988 Dec; 38(4):251-9. PubMed ID: 2467914
[TBL] [Abstract][Full Text] [Related]
10. Effects of recombinant human transforming growth factor-beta 1 or/and interleukin-6 on growth inhibition and proto-oncogene c-myc expression in human leukemia cells.
Feng R; Shen S; Hui H; Jin M
Chin Med J (Engl); 1997 Nov; 110(11):847-50. PubMed ID: 9772416
[TBL] [Abstract][Full Text] [Related]
11. Regulatory effects of transforming growth factor-beta on IL-2- and IL-4-dependent T cell-cycle progression.
Ruegemer JJ; Ho SN; Augustine JA; Schlager JW; Bell MP; McKean DJ; Abraham RT
J Immunol; 1990 Mar; 144(5):1767-76. PubMed ID: 2407783
[TBL] [Abstract][Full Text] [Related]
12. A c-myc antisense oligonucleotide inhibits human retinal pigment epithelial cell proliferation.
Capeáns C; Piñeiro A; Domínguez F; Loidi L; Buceta M; Carneiro C; Garcia-Caballero T; Sanchez-Salorio M
Exp Eye Res; 1998 May; 66(5):581-9. PubMed ID: 9628805
[TBL] [Abstract][Full Text] [Related]
13. Effects of human lymphoblastoid interferon on proliferation, gene expression and tumourigenicity of human hepatoma cell lines.
Huber BE; Wirth PJ; Newbold JE
Drugs Exp Clin Res; 1991; 17(6):281-91. PubMed ID: 1663028
[TBL] [Abstract][Full Text] [Related]
14. Tumor necrosis factor stimulates proliferation of human osteosarcoma cells and accumulation of c-myc messenger RNA.
Kirstein M; Baglioni C
J Cell Physiol; 1988 Mar; 134(3):479-84. PubMed ID: 2450880
[TBL] [Abstract][Full Text] [Related]
15. A c-myc antisense oligodeoxynucleotide inhibits entry into S phase but not progress from G0 to G1.
Heikkila R; Schwab G; Wickstrom E; Loke SL; Pluznik DH; Watt R; Neckers LM
Nature; 1987 Jul 30-Aug 5; 328(6129):445-9. PubMed ID: 3302722
[TBL] [Abstract][Full Text] [Related]
16. Consensus-interferon and platelet-derived growth factor adversely regulate proliferation and migration of Kaposi's sarcoma cells by control of c-myc expression.
Köster R; Blatt LM; Streubert M; Zietz C; Hermeking H; Brysch W; Stürzl M
Am J Pathol; 1996 Dec; 149(6):1871-85. PubMed ID: 8952524
[TBL] [Abstract][Full Text] [Related]
17. c-myc antisense oligodeoxyribonucleotides inhibit proliferation of non-small cell lung cancer.
Robinson LA; Smith LJ; Fontaine MP; Kay HD; Mountjoy CP; Pirruccello SJ
Ann Thorac Surg; 1995 Dec; 60(6):1583-91. PubMed ID: 8787447
[TBL] [Abstract][Full Text] [Related]
18. Cyclic AMP-mediated suppression of normal and neoplastic B cell proliferation is associated with regulation of myc and Ha-ras protooncogenes.
Blomhoff HK; Smeland EB; Beiske K; Blomhoff R; Ruud E; Bjøro T; Pfeifer-Ohlsson S; Watt R; Funderud S; Godal T
J Cell Physiol; 1987 Jun; 131(3):426-33. PubMed ID: 3036888
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of growth of human breast carcinoma cells by an antisense oligonucleotide targeted to the transferrin receptor gene.
Yang DC; Jiang XP; Elliott RL; Head JF
Anticancer Res; 2001; 21(3B):1777-87. PubMed ID: 11497259
[TBL] [Abstract][Full Text] [Related]
20. Differential dependence of the tumorigenicity of chemically transformed rat liver epithelial cells on autocrine production of transforming growth factor alpha.
Duddy SK; Earp HS; Russell WE; Smith GJ; Grisham JW
Cell Growth Differ; 1995 Mar; 6(3):251-61. PubMed ID: 7794793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]